Osaic Holdings’s Tourmaline Bio TRML Stock Holding History

Osaic Holdings’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-251	Closed	-$5.9K	–	8181
2025 Q3	$5.9K	Hold	251	–	–	﹤0.01%	6662
2025 Q2	$4.01K	Buy	251 +1	+0.4%	+$16	﹤0.01%	6662
2025 Q1	$3.8K	Hold	250	–	–	﹤0.01%	6318
2024 Q4	$5.07K	Hold	250	–	–	﹤0.01%	6188
2024 Q3	$6.43K	Hold	250	–	–	﹤0.01%	6092
2024 Q2	$3.21K	Hold	250	–	–	﹤0.01%	6394
2024 Q1	$5.72K	Hold	250	–	–	﹤0.01%	6020
2023 Q4	$6.54K	Buy	+250	New	+$5K	﹤0.01%	6043

Osaic Holdings's TRML Position: Q4 2025 in Review

Osaic Holdings sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 251 shares — an estimated $5.9K sold.

Osaic Holdings first reported a position in TRML in Q4 2023 and held it in 8 quarters. The position peaked at $6.54K in Q4 2023. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Osaic Holdings reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Osaic Holdings sold 251 Tourmaline Bio shares in Q4 2025, an estimated $5.9K.
Osaic Holdings first reported a position in Tourmaline Bio in Q4 2023 and held it in 8 quarters.
Osaic Holdings's Tourmaline Bio position peaked at $6.54K in Q4 2023.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.